Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Anemia

  Free Subscription


Articles published in Am J Hematol

Retrieve available abstracts of 198 articles:
HTML format
Text format



Single Articles


    July 2018
  1. HANINA S, Bain BJ, Clark B, Layton DM, et al
    Congenital sideroblastic anemia in a female.
    Am J Hematol. 2018 Jul 24. doi: 10.1002/ajh.25196.
    PubMed     Text format    


  2. SARNA K, Gebremedin A, Brittenham GM, Beall CM, et al
    WHO hemoglobin thresholds for altitude increase the prevalence of anemia among Ethiopian highlanders.
    Am J Hematol. 2018 Jul 24. doi: 10.1002/ajh.25194.
    PubMed     Text format    


  3. SHANDER A, Goodnough LT
    Management of anemia in patients who decline blood transfusion.
    Am J Hematol. 2018 Jul 22. doi: 10.1002/ajh.25167.
    PubMed     Text format    


  4. STRAUSS WE, Adkinson NF, Macdougall IC, Auerbach M, et al
    A response by Strauss et al. to "A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia".
    Am J Hematol. 2018 Jul 17. doi: 10.1002/ajh.25200.
    PubMed     Text format    


  5. BARCELLINI W, Zaninoni A, Fattizzo B, Giannotta JA, et al
    Predictors of refractoriness to therapy and healthcare resource utilization in 378 patients with primary autoimmune hemolytic anemia from 8 Italian Reference Centers.
    Am J Hematol. 2018 Jul 7. doi: 10.1002/ajh.25212.
    PubMed     Text format    


  6. MUNDY LM, Wohlfeil S
    A comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia.
    Am J Hematol. 2018 Jul 7. doi: 10.1002/ajh.25204.
    PubMed     Text format    


    June 2018
  7. PALMBLAD J, Sander B, Bain B, Klimkowska M, et al
    Congenital dyserythropoietic anemia type 1: a case with novel compound heterozygous mutations in the C15orf41 gene.
    Am J Hematol. 2018 Jun 8. doi: 10.1002/ajh.25157.
    PubMed     Text format    


  8. GANSNER JM, Furutani E, Campagna DR, Fleming MD, et al
    Pancreatic lipomatosis in Diamond-Blackfan anemia: The importance of genetic testing in bone marrow failure disorders.
    Am J Hematol. 2018 Jun 8. doi: 10.1002/ajh.25155.
    PubMed     Text format    


    May 2018
  9. TAYO BO, Akingbola TS, Saraf SL, Shah BN, et al
    Fixed Low-Dose Hydroxyurea for the Treatment of Adults with Sickle Cell Anemia in Nigeria.
    Am J Hematol. 2018 May 14. doi: 10.1002/ajh.25143.
    PubMed     Text format    


    April 2018
  10. ROY S, Rai P, Eiymo Mwa Mpollo MS, Chang KH, et al
    Angiotensin Receptor Signaling in Sickle Cell Anemia has a Reno-Protective effect on Urine Concentrating Ability but results in Sickle Glomerulopathy.
    Am J Hematol. 2018 Apr 20. doi: 10.1002/ajh.25118.
    PubMed     Text format    


  11. PENNA D, Nicolosi M, Vallapureddy RR, Szuber N, et al
    The impact of sex on disease phenotype and prognostic thresholds of anemia in myelodysplastic syndromes.
    Am J Hematol. 2018 Apr 16. doi: 10.1002/ajh.25114.
    PubMed     Text format    


    March 2018
  12. PERGOLA PE, Fishbane S, LeWinter RD, Neylan JF, et al
    Hemoglobin response to ferric citrate in patients with nondialysis-dependent chronic kidney disease and iron deficiency anemia.
    Am J Hematol. 2018 Mar 25. doi: 10.1002/ajh.25088.
    PubMed     Text format    


  13. DERMAN R, Roman E, Smith-Nguyen GN, Achebe MM, et al
    Iron isomaltoside is superior to iron sucrose in increasing hemoglobin in gynecological patients with iron deficiency anemia.
    Am J Hematol. 2018 Mar 23. doi: 10.1002/ajh.25094.
    PubMed     Text format    


  14. JORDAN LC, Williams DOR, Rodeghier MJ, Covert B, et al
    Children with sickle cell anemia with normal TCD and without silent infarcts have a low incidence of new strokes.
    Am J Hematol. 2018 Mar 9. doi: 10.1002/ajh.25085.
    PubMed     Text format     Abstract available


  15. BACIGALUPO A, Oneto R, Schrezenmeier H, Hochsmann B, et al
    First line treatment of aplastic anemia with thymoglobuline in europe and asia: Outcome of 955 patients treated 2001-2012.
    Am J Hematol. 2018 Mar 2. doi: 10.1002/ajh.25081.
    PubMed     Text format     Abstract available


  16. SCHMIDT PJ, Liu K, Visner G, Fitzgerald K, et al
    RNAi-mediated reduction of hepatic Tmprss6 diminishes anemia and secondary iron overload in a splenectomized mouse model of beta-thalassemia intermedia.
    Am J Hematol. 2018 Mar 2. doi: 10.1002/ajh.25079.
    PubMed     Text format     Abstract available


  17. GALADANCI NA, Umar Abdullahi S, Vance LD, Musa Tabari A, et al
    Feasibility trial for primary stroke prevention in children with sickle cell anemia in Nigeria (SPIN trial).
    Am J Hematol. 2018;93:E83.
    PubMed     Text format    


    February 2018
  18. ADKINSON NF, Strauss WE, Macdougall IC, Bernard KE, et al
    Comparative safety of intravenous ferumoxytol vs ferric carboxymaltose in iron deficiency anemia: A randomized trial.
    Am J Hematol. 2018 Feb 8. doi: 10.1002/ajh.25060.
    PubMed     Text format     Abstract available


    January 2018
  19. PEFFAULT DE LATOUR R, Tabrizi R, Marcais A, Leblanc T, et al
    Nationwide Survey on the Use of Horse Antithymocyte Globulins (ATGAM) in Patients with Acquired Aplastic Anemia: A Report on Behalf of the French Reference Center for Aplastic Anemia.
    Am J Hematol. 2018 Jan 27. doi: 10.1002/ajh.25050.
    PubMed     Text format     Abstract available


  20. JEREBTSOVA M, Saraf SL, Soni S, Afangbedji N, et al
    Urinary Orosomucoid is Associated with Progressive Chronic Kidney Disease Stage in Patients with Sickle Cell Anemia.
    Am J Hematol. 2018 Jan 12. doi: 10.1002/ajh.25036.
    PubMed     Text format    


  21. VANHINSBERGH L, Uthaya S, Bain BJ
    Methylene blue-induced Heinz body hemolytic anemia in a premature neonate.
    Am J Hematol. 2018 Jan 5. doi: 10.1002/ajh.25028.
    PubMed     Text format    


  22. ANDOLFO I, Russo R, Gambale A, Iolascon A, et al
    Hereditary stomatocytosis: An underdiagnosed condition.
    Am J Hematol. 2018;93:107-121.
    PubMed     Text format     Abstract available


    December 2017
  23. FATTIZZO B, Zaninoni A, Gianelli U Prof, Zanella A Prof, et al
    Prognostic impact of bone marrow fibrosis and dyserythropoiesis in autoimmune hemolytic anemia.
    Am J Hematol. 2017 Dec 23. doi: 10.1002/ajh.25020.
    PubMed     Text format    


  24. WILLEN SM, Rodeghier M, Rosen CL, DeBaun MR, et al
    Sleep disordered breathing does not predict acute severe pain episodes in children with sickle cell anemia.
    Am J Hematol. 2017 Dec 20. doi: 10.1002/ajh.25013.
    PubMed     Text format     Abstract available


  25. WILLEN SM, Cohen R, Rodeghier M, Kirkham F, et al
    Age is the only predictor of small decrease in lung function in children with sickle cell anemia.
    Am J Hematol. 2017 Dec 11. doi: 10.1002/ajh.25003.
    PubMed     Text format     Abstract available


  26. DAVIES JOJ, Hart AC, De La Fuente J, Bain BJ, et al
    Macrophage activation syndrome and post-transplant microangiopathy following haploidentical bone marrow transplantation for sickle cell anemia.
    Am J Hematol. 2017 Dec 2. doi: 10.1002/ajh.24995.
    PubMed     Text format    


  27. DE FALCO L, Tortora R, Imperatore N, Bruno M, et al
    The role of tmprss6 and hfe variants in iron deficiency anemia in celiac disease.
    Am J Hematol. 2017 Dec 1. doi: 10.1002/ajh.24991.
    PubMed     Text format     Abstract available


  28. PINTO VM, Gianesin B, Balocco M, Bacigalupo L, et al
    Noninvasive monitoring of liver fibrosis in sickle cell disease: Longitudinal observation of a cohort of adult patients.
    Am J Hematol. 2017;92:E666-E668.
    PubMed     Text format    


  29. TAHER AT, Saliba AN, Kuo KH, Giardina PJ, et al
    Safety and pharmacokinetics of the oral iron chelator SP-420 in beta-thalassemia.
    Am J Hematol. 2017;92:1356-1361.
    PubMed     Text format     Abstract available


  30. NARBEY D, Habibi A, Chadebech P, Mekontso-Dessap A, et al
    Incidence and predictive score for delayed hemolytic transfusion reaction in adult patients with sickle cell disease.
    Am J Hematol. 2017;92:1340-1348.
    PubMed     Text format     Abstract available


  31. SALIBA AN, Moukhadder HM, Harb A, Beydoun H, et al
    Causes of hospital admission in beta-thalassemia (CHAT) in Lebanon from 1995 to 2015: A pilot retrospective study from a tertiary care center.
    Am J Hematol. 2017;92:E652-E653.
    PubMed     Text format    


  32. CAOCCI G, Orofino MG, Vacca A, Piroddi A, et al
    Long-term survival of beta thalassemia major patients treated with hematopoietic stem cell transplantation compared with survival with conventional treatment.
    Am J Hematol. 2017;92:1303-1310.
    PubMed     Text format     Abstract available


  33. WORSHAM CM, Martin ST, Nouraie SM, Cohen RT, et al
    Clinical and laboratory findings associated with sleep disordered breathing in sickle cell disease.
    Am J Hematol. 2017;92:E649-E651.
    PubMed     Text format    


  34. SCHARMAN CD, Burger D, Shatzel JJ, Kim E, et al
    Treatment of individuals who cannot receive blood products for religious or other reasons.
    Am J Hematol. 2017;92:1370-1381.
    PubMed     Text format     Abstract available


    November 2017
  35. CASALE M, Borriello A, Scianguetta S, Roberti D, et al
    Hereditary hypochromic microcytic anemia associated with loss-of-function DMT1 gene mutations and absence of liver iron overload.
    Am J Hematol. 2017 Nov 27. doi: 10.1002/ajh.24988.
    PubMed     Text format    


  36. MACHARIA AW, Mochamah G, Uyoga S, Ndila CM, et al
    The clinical epidemiology of sickle cell anemia in Africa.
    Am J Hematol. 2017 Nov 23. doi: 10.1002/ajh.24986.
    PubMed     Text format     Abstract available


  37. KHALEEL M, Puliyel M, Shah P, Sunwoo J, et al
    Individuals with sickle cell disease have a significantly greater vasoconstriction response to thermal pain than controls and have significant vasoconstriction in response to anticipation of pain.
    Am J Hematol. 2017;92:1137-1145.
    PubMed     Text format     Abstract available


  38. SOLOVEY A, Somani A, Belcher JD, Milbauer L, et al
    A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.
    Am J Hematol. 2017;92:1119-1130.
    PubMed     Text format     Abstract available


  39. NADER E, Connes P, Lamarre Y, Renoux C, et al
    Plasmapheresis may improve clinical condition in sickle cell disease through its effects on red blood cell rheology.
    Am J Hematol. 2017;92:E629-E630.
    PubMed     Text format    


  40. SCHIMMEL M, Luken BM, Nur E, van Tuijn CFJ, et al
    Inflammatory and endothelial markers during vaso-occlusive crisis and acute chest syndrome in sickle cell disease.
    Am J Hematol. 2017;92:E634-E636.
    PubMed     Text format    


  41. ORIGA R, Tatti F, Zappu A, Leoni GB, et al
    Earlier initiation of transfusional and iron chelation therapies in recently born children with transfusion-dependent thalassemia.
    Am J Hematol. 2017;92:E627-E628.
    PubMed     Text format    


    October 2017
  42. GONZALES GF, Rubin de Celis V, Begazo J, Hinojosa MDR, et al
    Correcting the cut-off point of hemoglobin at high altitude favors misclassification of anemia, erythrocytosis and excessive erythrocytosis.
    Am J Hematol. 2017 Oct 6. doi: 10.1002/ajh.24932.
    PubMed     Text format    


  43. MARTINEZ C, Watson DJ, Shebl A, Wallenhorst C, et al
    Impact of screening and exclusion of high anti-A titer donors on the risk of hemolytic anemia with intravenous immunoglobulin treatment - a hospital-based cohort study in the US.
    Am J Hematol. 2017 Oct 6. doi: 10.1002/ajh.24931.
    PubMed     Text format    


  44. VAN TUIJN CFJ, Schimmel M, van Beers EJ, Nur E, et al
    Prospective evaluation of chronic organ damage in adult sickle cell patients: A seven-year follow-up study.
    Am J Hematol. 2017;92:E584-E590.
    PubMed     Text format     Abstract available


  45. SUN CW, Wu LC, Knopick PL, Bradley DS, et al
    Sickle cells produce functional immune modulators and cytotoxics.
    Am J Hematol. 2017;92:981-988.
    PubMed     Text format     Abstract available


  46. CAPPELLINI MD, Comin-Colet J, de Francisco A, Dignass A, et al
    Iron deficiency across chronic inflammatory conditions: International expert opinion on definition, diagnosis, and management.
    Am J Hematol. 2017;92:1068-1078.
    PubMed     Text format     Abstract available


  47. WAHIDIYAT PA, Sekarsari D, Adnani NB, Putriasih SA, et al
    Association of pancreatic MRI R2* with blood glucose and cardiac MRI R2* among thalassemia major patients in Indonesia.
    Am J Hematol. 2017;92:E620-E621.
    PubMed     Text format    


  48. AL-RIYAMI AZ, Iolascon A, Al-Zadjali S, Andolfo I, et al
    Targeted next generation sequencing identifies a novel beta-spectrin gene mutation A2059P in two Omani children with hereditary pyropoikilocytosis.
    Am J Hematol. 2017;92:E607-E609.
    PubMed     Text format    


    September 2017
  49. ESTEPP JH, Smeltzer MP, Kang G, Li C, et al
    A Clinically Meaningful Fetal Hemoglobin Threshold for Children with Sickle Cell Anemia During Hydroxyurea Therapy.
    Am J Hematol. 2017 Sep 14. doi: 10.1002/ajh.24906.
    PubMed     Text format     Abstract available


  50. ASARE EV, Olayemi E, Boafor T, Dei-Adomakoh Y, et al
    Implementation of multidisciplinary care reduces maternal mortality in women with sickle cell disease living in low-resource setting.
    Am J Hematol. 2017;92:872-878.
    PubMed     Text format     Abstract available


  51. BIALKOWSKI W, Kiss JE, Wright DJ, Cable R, et al
    Estimates of total body iron indicate 19 mg and 38 mg oral iron are equivalent for the mitigation of iron deficiency in individuals experiencing repeated phlebotomy.
    Am J Hematol. 2017;92:851-857.
    PubMed     Text format     Abstract available


  52. BARSHTEIN G, Goldschmidt N, Pries AR, Zelig O, et al
    Deformability of transfused red blood cells is a potent effector of transfusion-induced hemoglobin increment: A study with beta-thalassemia major patients.
    Am J Hematol. 2017;92:E559-E560.
    PubMed     Text format    


  53. SOOD R, Jiramongkolchai K, Streiff M, Gonzalez C, et al
    Look into my eyes: An unusual first presentation of sickle cell disease.
    Am J Hematol. 2017;92:968-971.
    PubMed     Text format    


  54. SIOW W, Matthey F, Bain BJ
    The significance of irregularly contracted cells and hemighosts in sickle cell disease.
    Am J Hematol. 2017;92:966-967.
    PubMed     Text format    


    August 2017
  55. BODDU P, Garcia-Manero G, Ravandi F, Borthakur G, et al
    Clinical Outcomes in Adult Patients with Aplastic Anemia- a single institution experience.
    Am J Hematol. 2017 Aug 29. doi: 10.1002/ajh.24897.
    PubMed     Text format     Abstract available


    July 2017
  56. ALVAREZ O, Nottage K, Simpson LM, Wood J, et al
    Kidney Function of Transfused Children with Sickle Cell Anemia: Baseline Data from the TWiTCH Study with Comparison to Non-Transfused Cohorts.
    Am J Hematol. 2017 Jul 25. doi: 10.1002/ajh.24871.
    PubMed     Text format    


  57. HABARA AH, Shaikho EM, Steinberg MH
    Fetal Hemoglobin in Sickle Cell Anemia: The Arab-Indian Haplotype and New Therapeutic Agents.
    Am J Hematol. 2017 Jul 24. doi: 10.1002/ajh.24872.
    PubMed     Text format     Abstract available


  58. WITZIG TE, Zinzani PL, Habermann TM, Tuscano JM, et al
    Long-Term Analysis of Phase II Studies of Single-Agent Lenalidomide in Relapsed/Refractory Mantle Cell Lymphoma.
    Am J Hematol. 2017 Jul 11. doi: 10.1002/ajh.24854.
    PubMed     Text format     Abstract available


  59. YEE MEM, Lane PA, Archer DR, Joiner CH, et al
    Estimation of Glomerular Filtration Rate Using Serum Cystatin C and Creatinine in Adults with Sickle Cell Anemia.
    Am J Hematol. 2017 Jul 3. doi: 10.1002/ajh.24840.
    PubMed     Text format    


  60. GLASSBERG J, Minnitti C, Cromwell C, Cytryn L, et al
    Inhaled steroids reduce pain and sVCAM levels in individuals with sickle cell disease: A triple-blind, randomized trial.
    Am J Hematol. 2017;92:622-631.
    PubMed     Text format     Abstract available


    June 2017
  61. VASSEUR C, Domingues-Hamdi E, Pakdaman S, Barau C, et al
    Elevated soluble alpha-hemoglobin pool in Sickle Cell Anemia.
    Am J Hematol. 2017 Jun 24. doi: 10.1002/ajh.24835.
    PubMed     Text format    


  62. KASTHURI RS, Montifar M, Nelson J, Kim H, et al
    Prevalence and Predictors of Anemia in Hereditary Hemorrhagic Telangiectasia.
    Am J Hematol. 2017 Jun 22. doi: 10.1002/ajh.24832.
    PubMed     Text format    


  63. SHAIKHO EM, Farrell JJ, Alsultan A, Sebastiani P, et al
    Genetic Determinants of HbF in Saudi Arabian and African Benin Haplotype Sickle Cell Anemia.
    Am J Hematol. 2017 Jun 13. doi: 10.1002/ajh.24822.
    PubMed     Text format    


  64. QUINN CT, Saraf SL, Gordeuk VR, Fitzhugh CD, et al
    Losartan for the Nephropathy of Sickle Cell Anemia: A Phase-2, Multi-Center Trial.
    Am J Hematol. 2017 Jun 7. doi: 10.1002/ajh.24810.
    PubMed     Text format     Abstract available


  65. GOMPERTS E, Belcher JD, Otterbein LE, Coates TD, et al
    The role of carbon monoxide and heme oxygenase in the prevention of sickle cell disease vaso-occlusive crises.
    Am J Hematol. 2017;92:569-582.
    PubMed     Text format     Abstract available


  66. HADJIDEMETRIOU M
    Thalassemia: Yesterday, Today, Tomorrow.
    Am J Hematol. 2017;92:490-492.
    PubMed     Text format    


  67. BALDINI M, Mancarella M, Cassinerio E, Marcon A, et al
    Adrenal insufficiency: An emerging challenge in thalassemia?
    Am J Hematol. 2017;92:E119-E121.
    PubMed     Text format    


  68. BRENNAN Y, Curnow J, Favaloro EJ
    2B or not 2B? A prothrombotic tendency masquerading as a bleeding disorder.
    Am J Hematol. 2017;92:584-590.
    PubMed     Text format    


  69. ANDERSON N, Eckman JR, Ballas SK
    Beyond the transition of adolescents and young adults with sickle cell disease to adult care: Role of geography.
    Am J Hematol. 2017;92:E110-E112.
    PubMed     Text format    


  70. RIVERA A, Vandorpe DH, Shmukler BE, Gallagher DR, et al
    Erythrocytes from hereditary xerocytosis patients heterozygous for KCNN4 V282M exhibit increased spontaneous Gardos channel-like activity inhibited by senicapoc.
    Am J Hematol. 2017;92:E108-E110.
    PubMed     Text format    


  71. ROUMI JE, Moukhadder HM, Graziadei G, Pennisi M, et al
    Pregnancy in beta-thalassemia intermedia at two tertiary care centers in Lebanon and Italy: A follow-up report on fetal and maternal outcomes.
    Am J Hematol. 2017;92:E96-E99.
    PubMed     Text format    


  72. LAMBERT MP, Witmer CM, Kwiatkowski JL
    Therapy induced iron deficiency in children treated with eltrombopag for immune thrombocytopenia.
    Am J Hematol. 2017;92:E88-E91.
    PubMed     Text format    


  73. MINNITI CP, Vichinsky E
    Lifespan care in SCD: Whom to transition, the patients or the health care system?
    Am J Hematol. 2017;92:487-489.
    PubMed     Text format    


    May 2017
  74. HANSEN BR, Bottner WA, Ravindran A, DeJesus R, et al
    A follow-up on Desiderosmia (olfactory craving), a novel symptom associated with iron deficiency anemia.
    Am J Hematol. 2017 May 31. doi: 10.1002/ajh.24806.
    PubMed     Text format    


  75. TAHER AT, Origa R, Perrotta S, Kourakli A, et al
    New film-coated tablet formulation of deferasirox is well tolerated in patients with thalassemia or lower-risk MDS: Results of the randomized, phase II ECLIPSE study.
    Am J Hematol. 2017;92:420-428.
    PubMed     Text format     Abstract available


  76. HALAWI R, Cappellini MD, Taher A
    A higher prevalence of hematologic malignancies in patients with thalassemia: Background and culprits.
    Am J Hematol. 2017;92:414-416.
    PubMed     Text format    


  77. READING NS, Ruiz-Bonilla JA, Christensen RD, Caceres-Perkins W, et al
    A patient with both methemoglobinemia and G6PD deficiency: A therapeutic conundrum.
    Am J Hematol. 2017;92:474-477.
    PubMed     Text format    


  78. HALAWI R, Beydoun H, Cappellini MD, Ferla V, et al
    Hematologic malignancies in thalassemia: Adding new cases to the repertoire.
    Am J Hematol. 2017;92:E68-E70.
    PubMed     Text format    


  79. FURLAN L, Graziadei G, Colombo G, Forzenigo LV, et al
    K. pneumoniae liver abscess following deferoxamine subcutaneous self-injection.
    Am J Hematol. 2017;92:480-481.
    PubMed     Text format    


  80. ANGELUCCI E, Pilo F, Coates TD
    Transplantation in thalassemia: Revisiting the Pesaro risk factors 25 years later.
    Am J Hematol. 2017;92:411-413.
    PubMed     Text format    


    April 2017
  81. GALADANCI N, Abdullahi SU, Vance LD, Tabari AM, et al
    Feasibility Trial for Primary Stroke Prevention in Children with Sickle Cell Anemia in Nigeria (SPIN Trial).
    Am J Hematol. 2017 Apr 25. doi: 10.1002/ajh.24770.
    PubMed     Text format     Abstract available


  82. RAVINDRAN A, Sankaran J, Jacob EK, Kreuter JD, et al
    High prevalence of monoclonal gammopathy among patients with warm autoimmune hemolytic anemia.
    Am J Hematol. 2017 Apr 24. doi: 10.1002/ajh.24765.
    PubMed     Text format    


  83. COURONNE L, Tertian G, Boutron A, Picard V, et al
    A Somatic Mosaicism in the G6PD Gene Inducing a Late Onset Chronic non Spherocytic Hemolytic Anemia.
    Am J Hematol. 2017 Apr 10. doi: 10.1002/ajh.24760.
    PubMed     Text format    


  84. HANSEN JW, Sandholdt H, Siersma V, Orskov AD, et al
    "Anemia is present years before myelodysplastic syndrome diagnosis - results from the pre-diagnostic period".
    Am J Hematol. 2017 Apr 6. doi: 10.1002/ajh.24757.
    PubMed     Text format    


  85. GRALL M, Azoulay E, Galicier L, Provot F, et al
    Thrombotic thrombocytopenic purpura misdiagnosed as autoimmune cytopenia: Causes of diagnostic errors and consequence on outcome. Experience of the French thrombotic microangiopathies reference centre.
    Am J Hematol. 2017;92:381-387.
    PubMed     Text format     Abstract available


  86. LI LY, Liu ZY, Liu H, Liu CY, et al
    Deep sequencing of whole genome exon in paroxysmal nocturnal hemoglobinuria.
    Am J Hematol. 2017;92:E51-E53.
    PubMed     Text format    


  87. STEHOUWER N, Edge P, Katie Park B, Piccone C, et al
    Acute pain in adolescents and young adults with sickle cell disease: Delayed and increased opioid dosing following transition to adult care.
    Am J Hematol. 2017;92:E40-E42.
    PubMed     Text format    


  88. MANU PEREIRA MD, Ropero P, Loureiro C, Vives Corrons JL, et al
    Low affinity hemoglobinopathy (Hb Vigo) due to a new mutation of beta globin gene (c200 A>T; Lys>Ile). A cause of rare anemia misdiagnosis.
    Am J Hematol. 2017;92:E38-E40.
    PubMed     Text format    


    March 2017
  89. NASSIN ML, Vergilio JA, Heeney MM, LaBelle JL, et al
    Neonatal Anemia: Revisiting the Enigmatic Pyknocyte.
    Am J Hematol. 2017 Mar 23. doi: 10.1002/ajh.24731.
    PubMed     Text format    


  90. LEWEN MO, Kavanagh PL, Sobota AE
    A comment on improving transcranial Doppler ultrasonography screening in children with sickle cell anemia.
    Am J Hematol. 2017 Mar 23. doi: 10.1002/ajh.24727.
    PubMed     Text format    


  91. MEKONTSO DESSAP A, Cecchini J, Chaar V, Marcos E, et al
    Telomere attrition in sickle cell anemia.
    Am J Hematol. 2017 Mar 15. doi: 10.1002/ajh.24721.
    PubMed     Text format    


  92. FARRUGGIA P, Puccio G, Ramenghi U, Colombatti R, et al
    Recombinant erythropoietin vs. blood transfusion care in infants with hereditary spherocytosis: A retrospective cohort study of A.I.E.O.P. patients (Associazione Italiana Emato-Oncologia Pediatrica).
    Am J Hematol. 2017 Mar 6. doi: 10.1002/ajh.24713.
    PubMed     Text format    


  93. PATNAIK MM, Tefferi A
    Refractory anemia with ring sideroblasts (RARS) and RARS with thrombocytosis (RARS-T): 2017 update on diagnosis, risk-stratification, and management.
    Am J Hematol. 2017;92:297-310.
    PubMed     Text format     Abstract available


  94. SALIBA AN, Musallam KM, Cappellini MD, Graziadei G, et al
    Serum ferritin values between 300 and 800 ng/mL in nontransfusion-dependent thalassemia: A probability curve to guide clinical decision making when MRI is unavailable.
    Am J Hematol. 2017;92:E35-E37.
    PubMed     Text format    


  95. SCHOTTEN N, Laarakkers CM, Roelofs RW, Origa R, et al
    EPO and hepcidin plasma concentrations in blood donors and beta-thalassemia intermedia are not related to commercially tested plasma ERFE concentrations.
    Am J Hematol. 2017;92:E29-E31.
    PubMed     Text format    


  96. BARCELLINI W, Fattizzo B, Zaninoni A, Valli V, et al
    Clinical evolution of autoimmune cytopenias to idiopathic cytopenias/dysplasias of uncertain significance (ICUS/IDUS) and bone marrow failure syndromes.
    Am J Hematol. 2017;92:E26-E29.
    PubMed     Text format    


  97. GRAFFEO L, Vitrano A, Giambona A, Scondotto S, et al
    The heterozygote state for beta-thalassemia detrimentally affects health outcomes.
    Am J Hematol. 2017;92:E23-E25.
    PubMed     Text format    


  98. SOKOL KA, Veluswamy RR, Zimmerman BS, Tummalapalli SL, et al
    Atypical hemolytic uremic syndrome associated with Capnocytophaga canimorsus.
    Am J Hematol. 2017;92:322.
    PubMed     Text format    


    February 2017
  99. HANSEN BR, Bottner WA, Ravindran A, DeJesus R, et al
    Desiderosmia (olfactory craving): A novel symptom associated with iron deficiency anemia.
    Am J Hematol. 2017 Feb 27. doi: 10.1002/ajh.24706.
    PubMed     Text format    


  100. LEAF RK, O'Brien KL, Leaf DE, Drews RE, et al
    Autoimmune hemolytic anemia in a young man with acute hepatitis E infection.
    Am J Hematol. 2017 Feb 23. doi: 10.1002/ajh.24699.
    PubMed     Text format    


  101. WHIPPLE NS, Schwartz JR, Nottage KA
    DAT-positive Plasmodium ovale malaria presenting in a child with sickle cell anemia.
    Am J Hematol. 2017 Feb 17. doi: 10.1002/ajh.24691.
    PubMed     Text format    


  102. BENNANI NN, LaPlant BR, Ansell SM, Habermann TM, et al
    Efficacy of the oral mTORC1 inhibitor everolimus in relapsed or refractory indolent lymphoma.
    Am J Hematol. 2017 Feb 17. doi: 10.1002/ajh.24671.
    PubMed     Text format     Abstract available


  103. ALELUIA MM, Santiago RP, da Guarda CC, Fonseca TC, et al
    Genetic Modulation of Fetal Hemoglobin in Hydroxyurea-Treated Sickle Cell Anemia.
    Am J Hematol. 2017 Feb 13. doi: 10.1002/ajh.24680.
    PubMed     Text format    


  104. CHATURVEDI S, Labib Ghafuri D, Kassim A, Rodeghier M, et al
    Elevated tricuspid regurgitant jet velocity, reduced forced expiratory volume in 1 second, and mortality in adults with sickle cell disease.
    Am J Hematol. 2017;92:125-130.
    PubMed     Text format     Abstract available


  105. WRAY K, Allen A, Evans E, Fisher C, et al
    Hepcidin detects iron deficiency in Sri Lankan adolescents with a high burden of hemoglobinopathy: A diagnostic test accuracy study.
    Am J Hematol. 2017;92:196-203.
    PubMed     Text format     Abstract available


  106. VAN TUIJN CF, Sins JW, Fijnvandraat K, Biemond BJ, et al
    Daily pain in adults with sickle cell disease-a different perspective.
    Am J Hematol. 2017;92:179-186.
    PubMed     Text format     Abstract available


  107. DELVILLE M, Manceau S, Ait Abdallah N, Stolba J, et al
    Arterio-venous fistula for automated red blood cells exchange in patients with sickle cell disease: Complications and outcomes.
    Am J Hematol. 2017;92:136-140.
    PubMed     Text format     Abstract available


    January 2017
  108. DERMAN R, Roman E, Modiano MR, Okam MM, et al
    A randomized trial of iron isomaltoside versus iron sucrose in patients with iron deficiency anemia.
    Am J Hematol. 2017 Jan 4. doi: 10.1002/ajh.24633.
    PubMed     Text format     Abstract available


  109. DAI Y, Sangerman J, Nouraie M, Faller AD, et al
    Effects of hydroxyurea on F-cells in sickle cell disease and potential impact of a second fetal globin inducer.
    Am J Hematol. 2017;92:E10-E11.
    PubMed     Text format    


    December 2016
  110. JACOB SA, Novelli EM, Isenberg JS, Garrett ME, et al
    Thrombospondin-1 Gene Polymorphism is Associated with Estimated Pulmonary Artery Pressure in Patients with Sickle Cell Anemia.
    Am J Hematol. 2016 Dec 29. doi: 10.1002/ajh.24635.
    PubMed     Text format    


  111. RICCHI P, Costantini S, Spasiano A, Di Matola T, et al
    Myelolipoma among patients with thalassemia major and rare anemia with iron loading: A not so rare entity.
    Am J Hematol. 2016 Dec 22. doi: 10.1002/ajh.24622.
    PubMed     Text format    


  112. BAIN BJ
    Howell-Jolly bodies in acute hemolytic anemia.
    Am J Hematol. 2016 Dec 22. doi: 10.1002/ajh.24624.
    PubMed     Text format    


    October 2016
  113. GOODNOUGH LT, Comin-Colet J, Leal-Noval S, Ozawa S, et al
    Management of Anemia in Patients with Congestive Heart Failure.
    Am J Hematol. 2016 Oct 25. doi: 10.1002/ajh.24595.
    PubMed     Text format     Abstract available


  114. QUARMYNE MO, Dong W, Theodore R, Anand S, et al
    Hydroxyurea Effectiveness in Children and Adolescents with Sickle Cell Anemia: A Large Retrospective, Population-Based Cohort.
    Am J Hematol. 2016 Oct 19. doi: 10.1002/ajh.24587.
    PubMed     Text format     Abstract available


  115. MICHEL M, Terriou L, Roudot-Thoraval F, Hamidou M, et al
    A Randomized and Double-Blind Controlled Trial Evaluating the Safety and Efficacy of Rituximab for Warm Auto-Immune Hemolytic Anemia in Adults (the RAIHA study).
    Am J Hematol. 2016 Oct 3. doi: 10.1002/ajh.24570.
    PubMed     Text format     Abstract available


    September 2016
  116. QUINN CT, Smith EP, Arbabi S, Khera PK, et al
    Biochemical surrogate markers of hemolysis do not correlate with directly measured erythrocyte survival in sickle cell anemia.
    Am J Hematol. 2016 Sep 20. doi: 10.1002/ajh.24562.
    PubMed     Text format     Abstract available


  117. DONKER AE, Schaap CC, Novotny VM, Smeets R, et al
    Iron Refractory Iron Deficiency Anemia (IRIDA): A heterogeneous disease that is not always iron refractory.
    Am J Hematol. 2016 Sep 19. doi: 10.1002/ajh.24561.
    PubMed     Text format     Abstract available


  118. DEITERING S, Anslemo L, Burnett A, Jakeman B, et al
    Safety and effectiveness of extended versus shortened iron dextran infusion time for the treatment of iron deficiency anemia.
    Am J Hematol. 2016 Sep 15. doi: 10.1002/ajh.24555.
    PubMed     Text format    


  119. ATTA M, Brannigan ET, Bain BJ
    Cold autoimmune hemolytic anemia secondary to atypical pneumonia.
    Am J Hematol. 2016 Sep 6. doi: 10.1002/ajh.24550.
    PubMed     Text format    


    August 2016
  120. NARLA A, Davis NL, LaVasseur C, Wong C, et al
    Erythrocyte adenosine deaminase levels are elevated in Diamond Blackfan anemia but not in the 5q- syndrome.
    Am J Hematol. 2016 Aug 24. doi: 10.1002/ajh.24541.
    PubMed     Text format    


  121. CHATURVEDI S, Ghafuri DL, Glassberg J, Kassim AA, et al
    Rapidly progressive acute chest syndrome in individuals with sickle cell anemia.
    Am J Hematol. 2016 Aug 20. doi: 10.1002/ajh.24539.
    PubMed     Text format     Abstract available


  122. VATHIPADIEKAL V, Farrell JJ, Wang S, Edward HL, et al
    A Candidate Trans-acting Modulator of Fetal Hemoglobin Gene Expression in the Arab-Indian Haplotype of Sickle Cell Anemia: -ANTXR1 Variants and HbF.
    Am J Hematol. 2016 Aug 7. doi: 10.1002/ajh.24527.
    PubMed     Text format     Abstract available


    July 2016
  123. STEVENS H, Chua CC, Wallis M, Hew S, et al
    Fanconi anemia in 55 year-old identical twins first presenting as fatal post-chemotherapy pancytopenia.
    Am J Hematol. 2016 Jul 18. doi: 10.1002/ajh.24488.
    PubMed     Text format    


    June 2016
  124. CAOCCI G, La Nasa G, Bain BJ
    Erythroblast morphology in refractory anemia with ring sideroblasts.
    Am J Hematol. 2016 Jun 14. doi: 10.1002/ajh.24448.
    PubMed     Text format    


  125. VATHIPADIEKAL V, Alsultan A, Baltrusaitis K, Farrell JJ, et al
    Homozygosity for a haplotype in the HBG2-OR51B4 region is exclusive to Arab-Indian haplotype sickle cell anemia.
    Am J Hematol. 2016;91:E308-11.
    PubMed     Text format    


  126. RISITANO AM
    Paroxysmal nocturnal hemoglobinuria in the era of complement inhibition.
    Am J Hematol. 2016;91:359-60.
    PubMed     Text format    


  127. SHIREL T, Hubler CP, Shah R, Mager AB, et al
    Maternal opioid dose is associated with neonatal abstinence syndrome in children born to women with sickle cell disease.
    Am J Hematol. 2016;91:416-9.
    PubMed     Text format     Abstract available


  128. LOSCHI M, Porcher R, Barraco F, Terriou L, et al
    Impact of eculizumab treatment on paroxysmal nocturnal hemoglobinuria: a treatment versus no-treatment study.
    Am J Hematol. 2016;91:366-70.
    PubMed     Text format     Abstract available


    May 2016
  129. BALANDYA E, Reynolds T, Obaro S, Makani J, et al
    Alteration of Lymphocyte Phenotype and Function in Sickle Cell Anemia: Implications for Vaccine Responses.
    Am J Hematol. 2016 May 30. doi: 10.1002/ajh.24438.
    PubMed     Text format     Abstract available


  130. KROPSHOFER G, Sopper S, Steurer M, Schwinger W, et al
    Successful management of mixed chimerism after bone marrow transplant in beta-thalassemia major.
    Am J Hematol. 2016 May 30. doi: 10.1002/ajh.24436.
    PubMed     Text format    


  131. RISHI G, Secondes ES, Wallace DF, Subramaniam VN, et al
    Hematopoietic deletion of Transferrin Receptor 2 in mice leads to a block in erythroid differentiation during iron-deficient anemia.
    Am J Hematol. 2016 May 11. doi: 10.1002/ajh.24417.
    PubMed     Text format     Abstract available


  132. HEXNER EO, Luger SM, Reshef R, Jeschke GR, et al
    Infusion of CD3/CD28 costimulated umbilical cord blood T cells at the time of single umbilical cord blood transplantation may enhance engraftment.
    Am J Hematol. 2016;91:453-60.
    PubMed     Text format     Abstract available


  133. KAMMEYER R, Devnani R, Mehta R
    Cerebral fat embolism syndrome mimicking thrombotic thrombocytopenic purpura in a patient with hemoglobin SC disease.
    Am J Hematol. 2016;91:539-42.
    PubMed     Text format    


    April 2016
  134. URIO F, Lyimo M, Mtatiro SN, Cox SE, et al
    High Prevalence of Individuals with Low Concentration of Fetal Hemoglobin in F-cells in Sickle Cell Anemia in Tanzania.
    Am J Hematol. 2016 Apr 16. doi: 10.1002/ajh.24390.
    PubMed     Text format    


  135. MAURO FR, Coluzzi S, Paoloni F, Trastulli F, et al
    "Clinical characteristics and outcome of patients with autoimmune hemolytic anemia (AIHA) uniformly defined as primary by a diagnostic work-up".
    Am J Hematol. 2016 Apr 5. doi: 10.1002/ajh.24379.
    PubMed     Text format    


    March 2016
  136. SVAHN J, Bagnasco F, Cappelli E, Onofrillo D, et al
    Somatic, hematologic phenotype, long-term outcome and effect of hematopoietic stem cell transplantation. An analysis of 97 Fanconi Anemia patients from the Italian national database on behalf of the Marrow Failure Study Group of the AIEOP (Italian Ass
    Am J Hematol. 2016 Mar 25. doi: 10.1002/ajh.24373.
    PubMed     Text format     Abstract available


  137. O'CONNELL C, Horwood K, Nadamuni M
    Correction of refractory thrombocytopenia and anemia following withdrawal of extended release niacin.
    Am J Hematol. 2016 Mar 25. doi: 10.1002/ajh.24371.
    PubMed     Text format    


  138. WONG L, Smith S, Gilstrop M, Derman R, et al
    Safety and Efficacy of Rapid (1000 mg in one hour) Intravenous Iron Dextran for Treatment of Maternal Iron Deficient Anemia.
    Am J Hematol. 2016 Mar 11. doi: 10.1002/ajh.24361.
    PubMed     Text format     Abstract available


  139. SADREAMELI SC, Eakin MN, Robinson KT, Alade RO, et al
    Secondhand smoke is associated with more frequent hospitalizations in children with sickle cell disease.
    Am J Hematol. 2016;91:313-7.
    PubMed     Text format     Abstract available


  140. HILLMEN P, Muus P, Szer J, Hill A, et al
    Assessment of human antihuman antibodies to eculizumab after long-term treatment in patients with paroxysmal nocturnal hemoglobinuria.
    Am J Hematol. 2016;91:E16-7.
    PubMed     Text format    


  141. KNAPP E, Cohen H, Kutlar A, Ghalie R, et al
    Intrapatient variability in fetal hemoglobin measurements over time in sickle cell patients not on fetal hemoglobin inducing agents.
    Am J Hematol. 2016;91:E11-2.
    PubMed     Text format    


    February 2016
  142. PATNAIK MM, Lasho TL, Finke CM, Hanson CA, et al
    Predictors of survival in refractory anemia with ring sideroblasts and thrombocytosis (RARS-T) and the role of next-generation sequencing.
    Am J Hematol. 2016 Feb 13. doi: 10.1002/ajh.24332.
    PubMed     Text format     Abstract available


  143. PARTAIN DK, Botero JP, Shi M, Poterucha JJ, et al
    Spur Cell Anemia in the Setting of Progressive Liver Allograft Failure.
    Am J Hematol. 2016 Feb 13. doi: 10.1002/ajh.24331.
    PubMed     Text format    


  144. LUCHTMAN-JONES L, Pressel S, Hilliard L, Brown RC, et al
    Effects of hydroxyurea treatment for patients with hemoglobin SC disease.
    Am J Hematol. 2016;91:238-42.
    PubMed     Text format     Abstract available


  145. MCGANN PT, Schaefer BA, Paniagua M, Howard TA, et al
    Characteristics of a rapid, point-of-care lateral flow immunoassay for the diagnosis of sickle cell disease.
    Am J Hematol. 2016;91:205-10.
    PubMed     Text format     Abstract available


  146. ANEA CB, Lyon M, Lee IA, Gonzales JN, et al
    Pulmonary platelet thrombi and vascular pathology in acute chest syndrome in patients with sickle cell disease.
    Am J Hematol. 2016;91:173-8.
    PubMed     Text format     Abstract available


  147. LAYTON DM, Bain BJ
    Dehydrated hereditary stomatocytosis.
    Am J Hematol. 2016;91:266.
    PubMed     Text format    


    January 2016
  148. BOUCHNITA A, Eymard N, Moyo TK, Koury MJ, et al
    Bone marrow infiltration by multiple myeloma causes anemia by reversible disruption of erythropoiesis.
    Am J Hematol. 2016 Jan 9. doi: 10.1002/ajh.24291.
    PubMed     Text format     Abstract available


  149. CHATURVEDI S, DeBaun MR
    Evolution of sickle cell disease from a life-threatening disease of children to a chronic disease of adults: The last 40 years.
    Am J Hematol. 2016;91:5-14.
    PubMed     Text format     Abstract available


  150. RUND D
    Thalassemia 2016: Modern medicine battles an ancient disease.
    Am J Hematol. 2016;91:15-21.
    PubMed     Text format     Abstract available


  151. MINNITI CP, Kato GJ
    Critical Reviews: How we treat sickle cell patients with leg ulcers.
    Am J Hematol. 2016;91:22-30.
    PubMed     Text format     Abstract available


    November 2015
  152. BABUSHOK DV, Grignon AL, Li Y, Atienza J, et al
    Disrupted lymphocyte homeostasis in hepatitis-associated acquired aplastic anemia is associated with short telomeres.
    Am J Hematol. 2015 Nov 30. doi: 10.1002/ajh.24256.
    PubMed     Text format     Abstract available


  153. TEFFERI A, Cerquozzi S, Liaw J
    Bendamustine therapy associated resolution of anemia and splenomegaly in myelofibrosis.
    Am J Hematol. 2015 Nov 20. doi: 10.1002/ajh.24248.
    PubMed     Text format    


  154. VADHAN-RAJ S, Ford DC, Dahl NV, Bernard K, et al
    Safety and efficacy of ferumoxytol for the episodic treatment of iron deficiency anemia in patients with a history of unsatisfactory oral iron therapy: Results of a phase III, open-label, 6-month extension study.
    Am J Hematol. 2015 Nov 17. doi: 10.1002/ajh.24240.
    PubMed     Text format    


  155. FILLIATRE L, Broseus J, Pissard S, Mekki C, et al
    Amyl nitrite inhalation, a "volatile" anemia.
    Am J Hematol. 2015 Nov 3. doi: 10.1002/ajh.24229.
    PubMed     Text format    


  156. FOUQUET G, Guidez S, Petillon MO, Louni C, et al
    Lenalidomide is safe and active in Waldenstrom macroglobulinemia.
    Am J Hematol. 2015;90:1055-9.
    PubMed     Text format     Abstract available


  157. RICCHI P, Meloni A, Spasiano A, Neri MG, et al
    Extramedullary hematopoiesis is associated with lower cardiac iron loading in chronically transfused thalassemia patients.
    Am J Hematol. 2015;90:1008-12.
    PubMed     Text format     Abstract available


    October 2015
  158. GARDNER K, Thein SL
    Super-elevated LDH and thrombocytopenia are markers of a severe subtype of vaso-occlusive crisis in sickle cell disease.
    Am J Hematol. 2015;90:E206-7.
    PubMed     Text format    


  159. ANDOLFO I, Russo R, Manna F, Shmukler BE, et al
    Novel Gardos channel mutations linked to dehydrated hereditary stomatocytosis (xerocytosis).
    Am J Hematol. 2015;90:921-6.
    PubMed     Text format     Abstract available


    September 2015
  160. HANKINS JS, McCarville MB, Rankine-Mullings A, Reid ME, et al
    Prevention of conversion to abnormal tcd with hydroxyurea in sickle cell anemia: A phase III international randomized clinical trial.
    Am J Hematol. 2015 Sep 28. doi: 10.1002/ajh.24198.
    PubMed     Text format     Abstract available


  161. AUERBACH M, Adamson JW
    How We Diagnose and Treat Iron Deficiency Anemia.
    Am J Hematol. 2015 Sep 26. doi: 10.1002/ajh.24201.
    PubMed     Text format     Abstract available


  162. CASTRO O, Kato GJ
    Iron restriction in sickle cell anemia: Time for controlled clinical studies.
    Am J Hematol. 2015 Sep 16. doi: 10.1002/ajh.24193.
    PubMed     Text format    


  163. FREEMAN AT, Ataga KI
    Pulmonary Endarterectomy as Treatment for Chronic Thromboembolic Pulmonary Hypertension in Sickle Cell Disease.
    Am J Hematol. 2015 Sep 15. doi: 10.1002/ajh.24192.
    PubMed     Text format    


  164. SALIBA AN, Taher AT
    Comment on "deferiprone versus deferoxamine in thalassemia intermedia: results from a 5-year long-term Italian multicenter randomized clinical trial".
    Am J Hematol. 2015;90:E192-3.
    PubMed     Text format    


  165. LUND K, Chakravorty S, Toma S, Bain BJ, et al
    Compound heterozygosity for hemoglobins S and D.
    Am J Hematol. 2015;90:842.
    PubMed     Text format    


  166. O'REILLY MA, Millar SR, Buckley CM, Harrington JM, et al
    Smoking as an independent risk factor for macrocytosis in middle-aged adults: a population-based observational study.
    Am J Hematol. 2015;90:E196-7.
    PubMed     Text format    


  167. CHANDRAN R, Moran A, Barash M, Hopper B, et al
    A case of acute chest syndrome complicated by diffuse cerebral infarcts in an adult with HbSbeta-thalassemia(.).
    Am J Hematol. 2015;90:E197.
    PubMed     Text format    


  168. GRACE RF, Zanella A, Neufeld EJ, Morton DH, et al
    Erythrocyte pyruvate kinase deficiency: 2015 status report.
    Am J Hematol. 2015;90:825-30.
    PubMed     Text format     Abstract available


  169. SINGER ST, Killilea D, Suh JH, Wang ZJ, et al
    Fertility in transfusion-dependent thalassemia men: effects of iron burden on the reproductive axis.
    Am J Hematol. 2015;90:E190-2.
    PubMed     Text format    


  170. MELONI A, Restaino G, Missere M, De Marchi D, et al
    Pancreatic iron overload by T2* MRI in a large cohort of well treated thalassemia major patients: can it tell us heart iron distribution and function?
    Am J Hematol. 2015;90:E189-90.
    PubMed     Text format    


  171. CHEN M, Loh SF, Yu SL, Nair S, et al
    Rapid and reliable preimplantation genetic diagnosis of common hemoglobin Bart's hydrops fetalis syndrome and hemoglobin H disease determinants using an enhanced single-tube decaplex polymerase chain reaction assay.
    Am J Hematol. 2015;90:E194-6.
    PubMed     Text format    


  172. KOURELIS TV, Buckner JC, Gangat N, Patnaik MM, et al
    Temozolomide induced bone marrow Suppression--A single institution outcome analysis and review of the literature.
    Am J Hematol. 2015;90:E183-4.
    PubMed     Text format    


    August 2015
  173. MCGANN PT, Tyburski EA, de Oliveira V, Santos B, et al
    An accurate and inexpensive color-based assay for detecting severe anemia in a limited-resource setting.
    Am J Hematol. 2015 Aug 28. doi: 10.1002/ajh.24180.
    PubMed     Text format     Abstract available


  174. DEL MAR MANU-PEREIRA M, Gonzalez-Roca E, van Solinge WW, Llaudet-Planas E, et al
    Pyruvate kinase deficiency and severe congenital hemolytic anemia in a double heterozygous patient with paternal transmission of an early germ-line de novo mutation.
    Am J Hematol. 2015 Aug 28. doi: 10.1002/ajh.24178.
    PubMed     Text format    


  175. HERBAUX C, Duployez N, Badens C, Poret N, et al
    Incidence of ATRX mutations in myelodysplastic syndromes, the value of microcytosis.
    Am J Hematol. 2015;90:737-8.
    PubMed     Text format     Abstract available


  176. DESAI PC, Deal AM, Pfaff ER, Qaqish B, et al
    Alloimmunization is associated with older age of transfused red blood cells in sickle cell disease.
    Am J Hematol. 2015;90:691-5.
    PubMed     Text format     Abstract available


  177. FATTIZZO B, Zaninoni A, Nesa F, Sciumbata VM, et al
    Lessons from very severe, refractory, and fatal primary autoimmune hemolytic anemias.
    Am J Hematol. 2015;90:E149-51.
    PubMed     Text format    


  178. GIRI N, Alter BP, Penrose K, Falk RT, et al
    Immune status of patients with inherited bone marrow failure syndromes.
    Am J Hematol. 2015;90:702-8.
    PubMed     Text format     Abstract available


    July 2015
  179. ARCHER N, Galacteros F, Brugnara C
    2015 Clinical Trials Update in Sickle Cell Anemia.
    Am J Hematol. 2015 Jul 15. doi: 10.1002/ajh.24116.
    PubMed     Text format     Abstract available


  180. STEENSMA DP, Dakhil SR, Novotny PJ, Sloan JA, et al
    A Randomized Comparison of Once Weekly Epoetin Alfa to Extended Schedule Epoetin or Darbepoetin in Chemotherapy-Associated Anemia.
    Am J Hematol. 2015 Jul 6. doi: 10.1002/ajh.24110.
    PubMed     Text format     Abstract available


  181. ADEKILE A, Menzel S, Gupta R, Al-Sharida S, et al
    Response to hydroxyurea among Kuwaiti patients with sickle cell disease and elevated baseline HbF levels.
    Am J Hematol. 2015;90:E138-9.
    PubMed     Text format    


  182. FOZZA C, Pardini S, Giannico DB, Targhetta C, et al
    Dramatic erythroid response to low-dose thalidomide in two patients with transfusion independent thalassemia and severe post-transfusional alloimmune hemolysis.
    Am J Hematol. 2015;90:E141.
    PubMed     Text format    


  183. CALVARUSO G, Vitrano A, Di Maggio R, Lai E, et al
    Deferiprone versus deferoxamine in thalassemia intermedia: Results from a 5-year long-term Italian multicenter randomized clinical trial.
    Am J Hematol. 2015;90:634-8.
    PubMed     Text format     Abstract available


  184. JASPERS A, Baron F, Maertens J, De Prijck B, et al
    Long-term safety follow-up of a randomized trial of darbepoetin alpha and intravenous iron following autologous hematopoietic cell transplantation.
    Am J Hematol. 2015;90:E133-4.
    PubMed     Text format    


    June 2015
  185. JASPERS A, Baron F, Servais S, Lejeune M, et al
    Erythropoietin therapy after allogeneic hematopoietic cell transplantation has no impact on long-term survival.
    Am J Hematol. 2015 Jun 25. doi: 10.1002/ajh.24100.
    PubMed     Text format    


  186. WOOD JC, Pressel S, Rogers ZR, Odame I, et al
    Liver iron concentration measurements by MRI in chronically transfused children with sickle cell anemia: Baseline results from the TWiTCH trial.
    Am J Hematol. 2015 Jun 19. doi: 10.1002/ajh.24089.
    PubMed     Text format     Abstract available


  187. PIETY NZ, Yang X, Lezzar D, George A, et al
    A rapid paper-based test for quantifying sickle hemoglobin in blood samples from patients with sickle cell disease.
    Am J Hematol. 2015;90:478-82.
    PubMed     Text format     Abstract available


    May 2015
  188. NICHELE I, Ruggeri M, Rodeghiero F
    Effectiveness of lenalidomide in a patient with refractory anemia with ring sideroblasts and thrombocytosis with JAK2 (V617F) mutation.
    Am J Hematol. 2015 May 11. doi: 10.1002/ajh.24049.
    PubMed     Text format    


  189. RENELLA R
    Age-dependent pathophysiology of acute chest syndrome in children with sickle cell disease.
    Am J Hematol. 2015;90:367-8.
    PubMed     Text format    


  190. FIANCHI L, Pagano L, Piciocchi A, Candoni A, et al
    Characteristics and outcome of therapy-related myeloid neoplasms: Report from the Italian network on secondary leukemias.
    Am J Hematol. 2015;90:E80-5.
    PubMed     Text format     Abstract available


  191. FERRONE FA
    The delay time in sickle cell disease after 40 years: A paradigm assessed.
    Am J Hematol. 2015;90:438-45.
    PubMed     Text format     Abstract available


  192. LANZKRON S, Carroll CP, Hill P, David M, et al
    Impact of a dedicated infusion clinic for acute management of adults with sickle cell pain crisis.
    Am J Hematol. 2015;90:376-80.
    PubMed     Text format     Abstract available


  193. REESE JA, Bougie DW, Curtis BR, Terrell DR, et al
    Drug-induced thrombotic microangiopathy: Experience of the Oklahoma Registry and the BloodCenter of Wisconsin.
    Am J Hematol. 2015;90:406-10.
    PubMed     Text format     Abstract available


  194. MANWANI D, Chen G, Carullo V, Serban S, et al
    Single-dose intravenous gammaglobulin can stabilize neutrophil Mac-1 activation in sickle cell pain crisis.
    Am J Hematol. 2015;90:381-5.
    PubMed     Text format     Abstract available


    April 2015
  195. PICOT J, Ndour PA, Lefevre SD, El Nemer W, et al
    A biomimetic microfluidic chip to study the circulation and mechanical retention of red blood cells in the spleen.
    Am J Hematol. 2015;90:339-45.
    PubMed     Text format     Abstract available


  196. SAVAGE WJ, Buchanan GR, Yawn BP, Afenyi-Annan AN, et al
    Evidence gaps in the management of sickle cell disease: A summary of needed research.
    Am J Hematol. 2015;90:273-5.
    PubMed     Text format    


  197. SCHIMMEL M, van Beers EJ, van Tuijn CF, Nur E, et al
    N-terminal pro-B-type natriuretic peptide, tricuspid jet flow velocity, and death in adults with sickle cell disease.
    Am J Hematol. 2015;90:E75-6.
    PubMed     Text format    


  198. SCHMIDT PJ, Racie T, Westerman M, Fitzgerald K, et al
    Combination therapy with a Tmprss6 RNAi-therapeutic and the oral iron chelator deferiprone additively diminishes secondary iron overload in a mouse model of beta-thalassemia intermedia.
    Am J Hematol. 2015;90:310-3.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Anemia is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: